Dr Nicoleta Moisoi is a committed scientist with more than 10 years research experience in leading UK and European research institutes, working on signalling mechanisms implicated in neurodegeneration, and genetic and pharmacologic disease intervention.
She took her PhD in Biophysics at the University of Bucharest, Romania. She went on to undertake post-doctoral research at NIMR-MRC, London, UK and the MRC Toxicology Unit, Leicester, UK and University of Leicester, Leicester, UK. She joined De 51³Ô¹Ïapp University, Leicester School of Pharmacy in 2016. Honours and awards throughout her career include Junior Associate of ICTP (Italy), Royal Society/NATO Fellowship (UK).
Her studies address mitochondrial homeostasis and its implication in aging and parkinsonism, and signaling mechanisms involved in cell death/cell survival. Her recent work has focused on mitochondria quality control signalling, identification and validation of novel druggable pathways in Parkinson’s disease.